These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26348372)

  • 41. Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllers.
    de Masson A; Kirilovsky A; Zoorob R; Avettand-Fenoel V; Morin V; Oudin A; Descours B; Rouzioux C; Autran B
    AIDS; 2014 Jul; 28(11):1567-77. PubMed ID: 24804861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Greater diversity of HIV DNA variants in the rectum compared to variants in the blood in patients without HAART.
    Avettand-Fenoel V; Hocqueloux L; Müller-Trutwin M; Prazuck T; Melard A; Chaix ML; Agoute E; Michau C; Rouzioux C
    J Med Virol; 2011 Sep; 83(9):1499-507. PubMed ID: 21739438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing.
    Salazar-Gonzalez JF; Salazar MG; Learn GH; Fouda GG; Kang HH; Mahlokozera T; Wilks AB; Lovingood RV; Stacey A; Kalilani L; Meshnick SR; Borrow P; Montefiori DC; Denny TN; Letvin NL; Shaw GM; Hahn BH; Permar SR;
    J Virol; 2011 Mar; 85(6):2751-63. PubMed ID: 21191008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells.
    Anderson JA; Archin NM; Ince W; Parker D; Wiegand A; Coffin JM; Kuruc J; Eron J; Swanstrom R; Margolis DM
    J Virol; 2011 May; 85(10):5220-3. PubMed ID: 21367910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy.
    Madhavi V; Ana-Sosa-Batiz FE; Jegaskanda S; Center RJ; Winnall WR; Parsons MS; Ananworanich J; Cooper DA; Kelleher AD; Hsu D; Pett S; Stratov I; Kramski M; Kent SJ
    J Infect Dis; 2015 Feb; 211(4):529-38. PubMed ID: 25170105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of the HIV-1 reservoir in CD4+ regulatory T cells by a Droplet Digital PCR based approach.
    Dunay GA; Solomatina A; Kummer S; Hüfner A; Bialek JK; Eberhard JM; Tolosa E; Hauber J; Schulze Zur Wiesch J
    Virus Res; 2017 Aug; 240():107-111. PubMed ID: 28720421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of a long-term discrepancy in drug-targeted genes in plasma HIV-1 RNA and PBMC HIV-1 DNA in the same patient.
    Usuku S; Noguchi Y; Sakamoto M; Adachi T; Sagara H; Sudo K; Nishizawa M; Kondo M; Tochikubo O; Imai M
    Jpn J Infect Dis; 2006 Apr; 59(2):122-5. PubMed ID: 16632914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type 1-infected subjects in the absence or presence of effective therapy.
    Derdeyn CA; Kilby JM; Miralles GD; Li LF; Sfakianos G; Saag MS; Hockett RD; Bucy RP
    J Infect Dis; 1999 Dec; 180(6):1851-62. PubMed ID: 10558941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.
    Mavigner M; Delobel P; Cazabat M; Dubois M; L'faqihi-Olive FE; Raymond S; Pasquier C; Marchou B; Massip P; Izopet J
    PLoS One; 2009 Oct; 4(10):e7658. PubMed ID: 19876401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic composition of replication competent clonal HIV-1 variants isolated from peripheral blood mononuclear cells (PBMC), HIV-1 proviral DNA from PBMC and HIV-1 RNA in serum in the course of HIV-1 infection.
    Edo-Matas D; van Gils MJ; Bowles EJ; Navis M; Rachinger A; Boeser-Nunnink B; Stewart-Jones GB; Kootstra NA; van 't Wout AB; Schuitemaker H
    Virology; 2010 Sep; 405(2):492-504. PubMed ID: 20638697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
    Pariente N; Pernas M; de la Rosa R; Gómez-Mariano G; Fernández G; Rubio A; López M; Benito JM; López-Galíndez C; Leal M; Domingo E; Martinez MA; Mas A
    J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2.
    LeGoff J; Roques P; Jenabian MA; Charpentier C; Brochier C; Bouhlal H; Gresenguet G; Frost E; Pepin J; Mayaud P; Belec L;
    Clin Microbiol Infect; 2015 Sep; 21(9):873.e1-9. PubMed ID: 26003280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Niubó J; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2012; 17(3):577-83. PubMed ID: 22301439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-1 infection of monocytes is directly related to the success of HAART.
    Almodóvar S; Del C Colón M; Maldonado IM; Villafañe R; Abreu S; Meléndez I; Domínguez C; Cuevas W; Collins TM; Lorenzo E
    Virology; 2007 Dec; 369(1):35-46. PubMed ID: 17707072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy.
    Di Biagio A; Rusconi S; Marzocchetti A; Signori A; Schiavetti I; Bruzzone B; Monno L; Punzi G; Colao MG; Penco G; Zazzi M; De Luca A;
    J Med Virol; 2014 Oct; 86(10):1648-55. PubMed ID: 25042976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reconstitution of HIV-1 reservoir following high-dose chemotherapy/autologous stem cell transplantation for lymphoma.
    Delagreverie HM; Gerard L; Chaillon A; Roelens M; Djerroudi L; Salmona M; Larghero J; Galicier L; Simon F; Oksenhendler E; Moins-Teisserenc H; Delaugerre C
    AIDS; 2019 Feb; 33(2):247-257. PubMed ID: 30325771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.
    Re MC; Vitone F; Biagetti C; Schiavone P; Alessandrini F; Bon I; de Crignis E; Gibellini D
    Clin Microbiol Infect; 2010 Jun; 16(6):640-6. PubMed ID: 19732081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An increasing proportion of monotypic HIV-1 DNA sequences during antiretroviral treatment suggests proliferation of HIV-infected cells.
    Wagner TA; McKernan JL; Tobin NH; Tapia KA; Mullins JI; Frenkel LM
    J Virol; 2013 Feb; 87(3):1770-8. PubMed ID: 23175380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.